Background: This study compared the effectiveness of dual antiplatelet therapy (DAPT) with
clopidogrel-aspirin with that of aspirin monotherapy (AM) in mild-to-moderate acute ischemic …

Background and Purpose—This study aimed to compare the effectiveness of dual
antiplatelet therapy with clopidogrel plus aspirin (DAPT) with that of aspirin monotherapy …

Background Recent clinical trials established the benefit of dual antiplatelet therapy with
aspirin and clopidogrel (DAPT‐AC) in early‐presenting patients with minor ischemic stroke …

Importance Dual antiplatelet therapy has been demonstrated to be superior to single
antiplatelet in reducing recurrent stroke among patients with transient ischemic attack or …

Abstract Background and Purpose The purpose of this study was to evaluate the association
between different antiplatelet therapy regimens and the functional outcomes and bleeding …

Background and Purpose—Antiplatelets are recommended for patients with acute
noncardioembolic stroke or transient ischemic attack. We compared the safety and efficacy …

Objectives. Stroke is a common condition after a transient ischemic attack (TIA) or minor
ischemic stroke (IS). Adding clopidogrel to aspirin may yield more beneficial outcomes than …

Background Dual antiplatelet treatment has been shown to lower the risk of recurrent stroke
as compared with aspirin alone when treatment is initiated early (≤ 24 hours) after an acute …

Background and Purpose—Two large-scale randomized controlled trials of recurrent stroke
prevention suggest that dual antiplatelet therapy with clopidogrel plus aspirin is beneficial …

The patient's profile drawing the greatest benefit from dual antiplatelet therapy (DAPT) after
a noncardioembolic, ischemic cerebrovascular event is not well characterized. Aim of this …